[{"data":1,"prerenderedAt":66},["ShallowReactive",2],{"q-nurse-107-2-medical-surgical-022":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":36,"lastmod":65},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"explanationDeep":22,"topics":23,"freq":26},"nurse-107-2-內外科護理學-022","nurse-107-2-medical-surgical-022",107,2,22,"有關青光眼藥物作用的敘述，下列何者正確？",{"A":14,"B":15,"C":16,"D":17},"縮瞳劑可抑制房水液排出","β腎上腺素阻斷劑可抑制房水液生成","乙醯膽鹼酶抑制劑可抑制房水液生成","前列腺素致效劑可抑制房水液生成","B",null,[],"本題考點是青光眼藥物如何降低眼壓——不外乎『減少房水生成』或『促進房水排出』兩機轉。依藥理學,β腎上腺素阻斷劑(如 timolol)作用於睫狀體上皮的β受體,抑制房水液生成而降眼壓,故 B 正確。(A)縮瞳劑(如 pilocarpine)是收縮瞳孔、拉開小樑網『促進』房水排出,非抑制排出;(C)乙醯膽鹼酶抑制劑屬副交感致效類,亦為縮瞳促排出而非抑制生成;(D)前列腺素致效劑(如 latanoprost)是增加葡萄膜鞏膜途徑的房水『排出』,非抑制生成。","降眼壓藥兩大策略對照:減少生成→β阻斷劑、碳酸酐酶抑制劑、α2致效劑;促進排出→前列腺素類(葡萄膜鞏膜路徑)、膽鹼激性縮瞳劑(小樑網路徑)。急性隅角閉鎖性青光眼常先用縮瞳劑快速開放隅角。β阻斷劑有氣喘與心搏過緩禁忌需留意。前列腺素類副作用為虹膜色素沉著與睫毛增長。",[24,27,29,32,34],{"term":25,"count":26},"青光眼",5,{"term":28,"count":10},"β腎上腺素阻斷劑",{"term":30,"count":31},"房水液",1,{"term":33,"count":31},"前列腺素致效劑",{"term":35,"count":31},"縮瞳劑",[37,41,46,50,55,60],{"webId":38,"stem":39,"number":40,"year":9,"session":10},"nurse-107-2-medical-surgical-023","有關鼻咽癌的常見病因，下列何者最不相關？",23,{"webId":42,"stem":43,"number":44,"year":45,"session":31},"nurse-108-1-medical-surgical-039","有關癌症常見的腫瘤標記之敘述，下列何者錯誤？",39,108,{"webId":47,"stem":48,"number":49,"year":45,"session":10},"nurse-108-2-medical-surgical-053","肺葉切除術後，常放置兩支胸管引流，下列敘述何者正確？",53,{"webId":51,"stem":52,"number":53,"year":54,"session":31},"nurse-110-1-medical-surgical-011","有關肝性腦病變之醫護處置，下列何者正確？",11,110,{"webId":56,"stem":57,"number":58,"year":59,"session":31},"nurse-111-1-medical-surgical-055","有關呼吸器的使用，通常會設定每分鐘數次深呼吸，其所要預防之首要合併症，下列何者正確？",55,111,{"webId":61,"stem":62,"number":63,"year":64,"session":10},"nurse-112-2-medical-surgical-009","下列何者可用來做為大腸癌手術後是否復發的參考指標？",9,112,"2026-09-04",1788510725092]